Financing Immunization

GAVI Financing Task Force

Contributors

Many people play a significant role in the work of the GAVI Financing Task Force by participating in groups on vaccine demand forecasting; procurement; ongoing work on financial sustainability; and/or reviewing background papers. We would like to thank the institutions these people represent and all of the independent experts for their time and thoughtful input.

Abt Associates Inc. Bethesda, USA	Asian Development Bank Manila, Philippines	Association Pour l'Aid a la Médecine Préventive, France
Aventis Pasteur International Lyon, France	Aventis Pasteur Toronto, Canada	Bangladesh Directorate General of Health Services, Finance Division
Basic Support for Institutionalizing Child Health (the BASICS Project) Arlington, USA	Bénin Directeur de la Recherche et Développement en Santé	Bénin Ministère d'Etat Chargé de la Coordination de l'Action Gouvernementale de la Prospective et du Développement
Bénin Ministère des Finances et de l'Economie	Biological E. Ltd Hyderabad, India	Centers for Disease Control Atlanta, USA
Centro de Ingenieria Genetica y Biotecnologia La Habana, Cuba	Chiron Behring GmbH & Co. Marburg, Germany	Department of Health London, UK
Faculté de Médecine, Tunisie	Fogarty International Center National Institutes of Health Bethesda, USA	Gates CVP at PATH Seattle, USA
Glaxo SmithKline Rixensart, Belgium	Harvard University Center for International Development and Department of Economics Cambridge, USA	Institute on Public-Private Partnerships for Health, Forum for Global Health Geneva, Switzerland
Institute for Global Health San Francisco, USA	International Aids Vaccine Institute (IAVI) New York, USA	International Monetary Fund Washington, D.C.
International Vaccine Institute Seoul, Korea	Johns Hopkins University Baltimore, MD, USA	Kiev City Sanitary and Epidemiology Department, Ukraine
Malaria Vaccine Institute, Rockville, USA	Medix Group, Zimbabwe	Merck Vaccine Division Merck and Company Inc. West Point, USA
Mojave Therapeutics Tarrytown, NY, USA	MRC Laboratories Banjul, The Gambia	National Institute of Allergies and Infectious Diseases (NIAID)/NIH Bethesda, USA
Pan American Health Organization (PAHO) Washington, D.C. USA	Parteurop S.A. Lyon, France	Partnerships for Health Reform Bethesda, USA
Rhein Biotech NV Masstricht, The Netherlands	The Rockefeller Foundation Vienna, USA	Royal Danish Ministry of Foreign Affairs Copenhagen, Denmark
Sabin Vaccine Institute Rockville, USA	Save the Children UK East and Central Africa Nairobi, Kenya	Ukraine Ministry of Finance
Ukraine Ministry of Health	UNICEF New York, USA	University of California at Los Angeles Los Angeles, CA, USA
University of California, Berkeley Berkeley, CA, USA	University of Maryland School of Medicine, Center for Vaccine Development Bethesda, USA	University of Massachusetts, Law Center McCormack Institute of Public Affairs Boston, USA
University of Melbourne Melbourne, Australia	University Research Corporation Bethesda, USA	US General Accounting Office Washington, D.C.
The World Bank Washington, D.C. USA	World Health Organization (WHO) Geneva, Switzerland	Wyeth Lederle Vaccines Radnor, USA
Wyeth-Ayerst Pharmaceuticals Philadelphia, USA	Zimbabwe Ministry of Health & Child Welfare	Zimbabwe Ministry of Health, EPI Unit

 

This document is also available to download as a Word document (approx. 49kb)

Introduction	Financing Task Force	Identifying long-term financing options
Promoting the development of new vaccines for low-income and middle-income countries	Forecasting vaccine demand	Capacity Building in Financial Management